-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
- Hausmann JS, Kennedy K, Simard JF, et al. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. The Lancet Rheumatology. [published online ahead of print 22 July 2021]. doi: 10.1016/S2665-9913(21)00175-2
- Strangfeld A, Schäfer M, Gianfrancesco MA, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. [published online ahead of print 27 January 2021]. doi: 10.1136/annrheumdis-2020-219498
- Robinson PC, Yazdany J, Machado PM. Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance. Curr Opin Rheumatol. [Published Online Ahead of Print 30 Dec 2020]. doi: https://doi.org/10.1097/BOR.0000000000000783. Epub ahead of print. PMID: 33394601.
- Grainger R, Machado PM, Robinson PC. Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes. Best Pract Res Clin Rheumatol. 2020 Dec 23:101657. doi: 10.1016/j.berh.2020.101657. Epub ahead of print. PMID: 33468418; PMCID: PMC7756169.
- Hyrich, K.L., Machado, P.M. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol (2020). https://doi.org/10.1038/s41584-020-00562-2
- (2020) [published online ahead of print, 25 November 2020] Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation, Expert Review of Clinical Immunology, doi: 10.1080/1744666X.2021.1847084
- Milena A. Gianfrancesco Liza A. Leykina Zara Izadi Tiffany Taylor Jeffrey A. Sparks Carly Harrison Laura Trupin Stephanie Rush Gabriela Schmajuk Patricia Katz Lindsay Jacobsohn Tiffany Y. Hsu Kristin M. D’Silva Naomi Serling‐Boyd Rachel Wallwork Derrick J. Todd Suleman Bhana Wendy Costello Rebecca Grainger Jonathan S. Hausmann Jean W. Liew Emily Sirotich Paul Sufka Zachary S. Wallace Pedro M Machado Philip C. Robinson Jinoos Yazdany on behalf of the COVID‐19 Global Rheumatology Alliance. [published online ahead of print, 03 November 2020].Race/ethnicity association with COVID‐19 outcomes in rheumatic disease: Data from the COVID‐19 Global Rheumatology Alliance Physician Registry. Arthritis & Rheumatology (2020) doi: https://doi.org/10.1002/art.41567
- Sirotich, E., Hausmann, J.S. Removing barriers and disparities in health: lessons from the COVID-19 pandemic. Nat Rev Rheumatol (2020). https://doi.org/10.1038/s41584-020-00524-8
- Ugarte-Gil, MF, et al. Characteristics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry. Global Rheumatology [published online ahead of print [15 Sept 2020]. doi: 10.46856/grp.10.e003
- Robinson, Philip C, Richards, Duncan, Tanner, Helen L, Feldmann, Marc. Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. [published online ahead of print, 04 September 2020]. The Lancet Rheumatology, 2020. doi: https://doi.org/10.1016/S2665-9913(20)30309-X
- Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2020 Aug 2:10.1002/art.41469. doi: 10.1002/art.41469. Epub ahead of print. PMID: 32741139; PMCID: PMC7435536.
- Jean W Liew, Suleman Bhana, Wendy Costello, Jonathan S Hausmann, Pedro M Machado, Philip C Robinson, Emily Sirotich, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Rebecca Grainger, for the COVID-19 Global Rheumatology Alliance. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice, Rheumatology https://doi.org/10.1093/rheumatology/keaa483
- Adam Kilian, Yu Pei Chock, Irvin J. Huang, Elizabeth R. Graef, Laura A. Upton, Aneka Khilnani, Sonia D. Silinsky Krupnikova, Ibrahim Almaghlouth, Laura C. Cappelli, Ruth Fernandez-Ruiz, Brittany A. Frankel, Jourdan Frankovich, Carly Harrison, Bharat Kumar, Kanika Monga, Jorge A. Rosario Vega, Namrata Singh, Jeffrey A. Sparks, Elaine Sullo, Kristen J. Young, Ali Duarte-Garcia, Michael Putman, Sindhu Johnson, Rebecca Grainger, Zachary S. Wallace, Jean W. Liew, Aruni Jayatilleke. Acute respiratory viral adverse events during use of antirheumatic disease therapies: a scoping review. [published online ahead of print, 2020 July 22]. Seminars in Arthritis and Rheumatism, 2020, ISSN 0049-0172, https://doi.org/10.1016/j.semarthrit.2020.07.007.
- Hausmann JS, Sufka P, Bhana S, Liew JW, Machado PM, Wallace ZS, et al. Conducting research in a pandemic: The power of social media. Eur J Rheumatol 21 July 2020; 10.5152/eurjrheum.2020.2066 [Epub Ahead of Print].
- Gianfrancesco M, Yazdany J, Robinson PC. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases [published online ahead of print, 2020 Jul 15]. Curr Opin Rheumatol. 2020;10.1097/BOR.0000000000000725. doi: 10.1097/BOR.0000000000000725
- Sebastian E. Sattui, Jean W. Liew, Elizabeth R. Graef, Ariella Coler-Reilly, Francis Berenbaum, Alí Duarte-García, Carly Harrison, Maximilian F. Konig, Peter Korsten, Michael S. Putman, Philip C. Robinson, Emily Sirotich, Manuel F. Ugarte-Gil, Kate Webb, Kristen J. Young, Alfred H.J. Kim & Jeffrey A. Sparks (2020) Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19, [published online ahead of print 3 Jul 2020]. Expert Review of Clinical Immunology, DOI: 10.1080/1744666X.2020.1792778
- Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. [Epub ahead of print 29 May 2020]. doi: 10.1136/annrheumdis-2020-217871
- Sirotich, E., Dillingham, S., Grainger, R., Hausmann, J.S. Capturing patient‐reported outcomes during the COVID‐19 pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey. Arthritis Care Res. [Epub ahead of print 9 May 2020]. doi:10.1002/acr.24257
- Konig MF, Kim AH, Scheetz MH, et al. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases; [Epub ahead of print 7 May 2020]. doi: 10.1136/annrheumdis-2020-217690
- Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology; [Epub ahead of print 6 May 2020]. doi: https://doi.org/10.1093/rheumatology/keaa191
- Gianfrancesco, MA. Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors’ reply. The Lancet Rheumatology; [Epub ahead of print 5 May 2020]. doi: doi.org/10.1016/S2665-9913(20)30125-9
- Gianfrancesco, MA, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology; [Epub ahead of print 16 April 2020]. doi: https://doi.org/10.1016/S2665-9913(20)30095-3
- Graef ER, Liew JW, Putman MS, et al. Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases; [Epub ahead of print 15 April 2020]. doi: https://doi.org/10.1136/annrheumdis-2020-217480
- Robinson, PC, Yazdany, J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat Rev Rheumatol; [Epub ahead of print 2 April 2020] doi: https://doi.org/10.1038/s41584-020-0418-0
- Yazdany J, Kim AH. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med; [Epub ahead of print 31 March 2020]. doi: https://doi.org/10.7326/M20-1334
- Kim AH, Sparks JA, Liew JW, et al, for the COVID-19 Global Rheumatology Alliance. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med; [Epub ahead of print 30 March 2020]. doi: https://doi.org/10.7326/M20-1223